Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer

IJMS, Free Full-Text

Deciphering the gene regulatory circuitry governing chemoresistance in Triple-Negative Breast Cancer

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer

RNA-Seq assay identifies target genes of MLL3 and MLL4 in metabolism.

Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin

Full article: Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer

IJMS, Free Full-Text

Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement - ScienceDirect

Revealing TNBC Specific Super Enhancers - BioTechniques

Cancers, Free Full-Text

Cancers, Free Full-Text

Cancers, Free Full-Text

Heterogeneity and transcriptional drivers of triple-negative breast cancer - ScienceDirect

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect